1 / 4

UK Respiratory Drug Market Trends, Size, Competitive Analysis and Forecast - 2019-2025

UK respiratory drug market was $11.1 billion in 2018 and is anticipated to grow at a substantial rate of 7.0% during the forecast period.

DIGITALG9
Download Presentation

UK Respiratory Drug Market Trends, Size, Competitive Analysis and Forecast - 2019-2025

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Orion Market Research UK Respiratory Drug Market Size, Segmentation, Share, Forecast, Analysis, Industry Report to 2025 Request a Free Sample of UK Respiratory Drug Market: https://www.omrglobal.com/request-sample/uk-respiratory-drug-market Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +1 646-755-7667, +91 780-304-0404

  2. UK respiratory drug market was $11.1 billion in 2018 and is anticipated to grow at a substantial rate of 7.0% during the forecast period. The rising prevalence of chronic respiratory diseases, increasing geriatric population, and technological advancement are the major factors augmenting the growth of the respiratory drug market in Europe. Respiratory drugs are used for treatment of patient from asthma attacks and other respiratory ailments. As the prevalence of asthma and other diseases increases across UK, the demand of respiratory drugs is also expected to increase for treatment purposes. As per International Monetary Fund GDP of the country was $2.9 trillion in 2017. UK comprises of England, Scotland, Wales and Northern Ireland. Total population of the country in 2017 was 65 million, out of which about 18% are of geriatric population. Mortalities related to asthma and COPD are high in UK and due to these a significant investment by government and people can be forecast in the near future. Request a Free Sample of UK Respiratory Drug Market: https://www.omrglobal.com/request-sample/uk-respiratory-drug-market The UK respiratory drug market is segmented on the basis of route of administration, application, and end-user. Based on the route of administration, the market is classified into oral, injectable, and inhalable. Moreover, on the basis of application, the market has been classified into asthma and COPD diseases. The asthma disease application segment dominated the regional market in 2018 and is further estimated to follow the same trend over the forecast period. This is mainly due to the high prevalence of asthma in the nation. In addition, based on the end-user, homecare and hospitals and clinics have been analyzed. A full Report of UK Respiratory Drug Market is Available Market: https://www.omrglobal.com/industry-reports/uk-respiratory-drug-market Furthermore, the market is characterized by the presence of several manufacturers that are developing and providing respiratory drug to cater to a wide range of customers within and outside the region. The major players of the UK respiratory drug market include AstraZeneca PLC, GlaxoSmithKline PLC, Novartis AG, F. Hoffmann-La Roche Ltd. and Teva Pharmaceuticals Industries Ltd. These players adopt various strategies to capitalize on market growth opportunities. Mergers and acquisitions, product launch, geographical expansion, partnerships, and collaborations are the majorly adopted strategies by the market players. Market Segmentation UK Respiratory Drug Market by Route of Administration

  3. •Oral •Injectable •Inhalable UK Respiratory Drug Market by Application •Asthma •Chronic Obstructive Pulmonary Disease (COPD) UK Respiratory Drug Market by End-User •Homecare •Hospitals and Clinics Company Profiles •Air Liquide S.A. •Aradigm Corp. •AstraZeneca PLC •Baxter International Inc. •Boehringer Ingelheim International GmbH •F. Hoffmann-La Roche Ltd. •GlaxoSmithKline PLC •Merck & Co. •Novartis AG •Omron Healthcare Inc. •Pfizer Inc. •Pulmatrix Inc. •ResMed Corp. •Savara, Inc. •Sunovion Pharmaceuticals

  4. For More Customized Data, Request for Report Customization@ https://www.omrglobal.com/report-customization/uk-respiratory-drug-market About Orion Market Research Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. Media Contact: Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +1 646-755-7667, +91 780-304-0404

More Related